
zzso zzso are in broad use for the treatment of zzso zzso zzso gastrointestinal zzso tumors and zzso zzso and in development in a number of other zzso zzso including zzso cancer, zzso lung cancer, pancreatic cancer, zzso zzso zzso cancer, breast cancer and zzso This Review outlines the zzso relationships of the 44 zzso zzso currently in zzso An overview of the zzso profile of each zzso and its stage in development is zzso Phase III clinical trials being conducted for licensing of these agents for specific indications and phase III zzso efficacy trials are described in detailed tables that include the disease zzso trial design including combination therapy, study end points, and projected or final zzso The relative frequency of zzso and zzso adverse events observed in zzso patients is described for a subset of agents in development in clinical trials sponsored by the National Cancer zzso No zzso comparisons were undertaken and no data from pharmaceutical zzso databases were zzso The zzso effects seem to be mechanistically based and predicted by zzso zzso zzso zzso of zzso are active in a wide variety of zzso and fill a unique niche for cancer zzso 

